In this role, Barry will be responsible for leading operations, communicating and implementing company mission, and guiding overall strategy, direction, and growth.
Previously, Barry served as the vice president of applied genomics at Illumina (NASDAQ: ILMN) where she integrated market development strategies with product and business model innovation to accelerate the application of genomics in medicine and personal healthcare.
Prior to Illumina, Barry spent seven years at Genaissance Pharmaceuticals, one of the first genomics startups focused on individualized medicine and DNA-based diagnostic testing, with the primary responsibility of promoting clinical genetics testing services for pharmaceutical clinical trials.
She holds a BS in biology from the University of Vermont and a MBA from the University of Connecticut School of Business.
Luna DNA is a genomic and medical research database powered by the blockchain and owned by its community. A Public Benefit Corp., Luna DNA enables people to own and share their genomic information for the greater good of the community and medical research.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer